We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02780011
Brief Title: Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies (AD3LE)

First Submitted : February 24, 2016
First Submitted that Met QC Criteria : May 20, 2016
First Posted : May 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 25, 2018
Last Update Posted : July 27, 2018